- In March 2024, Mojo Vision, a U.S.-based smart contact lens innovator, announced successful clinical testing of its prototype smart lens featuring real-time data display and biosensor integration for chronic disease monitoring. The lens uses microelectronics to track health metrics and relay data wirelessly to connected devices, marking a major advancement in wearable medical technology. This milestone underscores Mojo Vision’s leadership in next-gen diagnostic wearables and its focus on merging vision enhancement with disease management
- In February 2024, Innovega Inc. revealed progress in U.S. FDA trials for its iOptik smart contact lens platform, which combines augmented reality with continuous biometric tracking. The lens is designed to aid users with chronic health conditions by integrating display optics and health monitoring systems in a single wearable. This innovation reflects the increasing convergence of medical wearables and AR for personalized healthcare solutions
- In December 2023, Sensimed AG, a Swiss company known for its Triggerfish smart lens, expanded its global distribution network in Asia and the Middle East to support the growing demand for intraocular pressure monitoring in glaucoma patients. This move strengthens its market presence and meets the need for accessible, non-invasive ocular diagnostics in underserved regions
- In October 2023, Samsung Electronics filed new patents for biosensor-enabled contact lenses capable of measuring glucose levels and intraocular pressure through tear fluid. These developments indicate the company's potential entry into the smart medical lens space and reflect the growing interest of consumer tech giants in health-focused wearables
- In August 2023, Bausch + Lomb, in collaboration with a leading biotech firm, announced the initiation of research into biodegradable smart lenses for disease monitoring applications. The initiative aims to improve comfort, reduce waste, and support sustainability while integrating advanced diagnostic features.
